ExagenXGN

13F holders, Q2 2024 (June 30)
33holders +2
2new positions
0sold out
3famous investors
$1.82avg. 13F price*

At the end of Q2 2024, 33 institutions reported holding Exagen Inc. (XGN) in their 13F filings, up 2 from Q1 2024. 2 opened new positions and 0 sold out. The largest holders were RTW Investments, LP ($2.8M), Cowen and Company, LLC ($1.6M) and Wasatch Advisors LP ($1.4M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Exagen Inc.
CUSIP
30068X103
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 31Q1 2024Q2 2024: 33Q2 2024Q3 2024: 33Q3 2024Q4 2024: 41Q4 2024Q1 2025: 38Q1 2025Q2 2025: 53Q2 2025Q3 2025: 62Q3 2025Q4 2025: 80Q4 2025Q1 2026: 61Q1 2026Q2 2026: 57Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions2$140K
Exits0$0

All 13F filers, Q1 2024 → Q2 2024: 207,006 shares bought and 126,225 shares sold, net +80,781 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 33 holders

RTW Investments, LP 0.04% Add +0.5% 1,511,866 $2.8M
Cowen and Company, LLC 0.05% Reduce -0.8% 891,366 $1.6M
Wasatch Advisors LP 0.01% Reduce -3.1% 762,259 $1.4M
Silvercrest Asset Management Group LLC 0.01% No change 544,877 $992K
Perkins Capital Management Inc. 0.85% Reduce -0.1% 493,321 $898K
Vanguard Group Inc. 0.00% No change 490,944 $894K
Morgan Stanley 0.00% No change 482,420 $878K
Stonepine Capital Management, LLC 0.60% Reduce -6.7% 358,697 $653K
Renaissance Technologies 0.00% Add +93.3% 94,234 $172K
Geode Capital Management, LLC 0.00% Add +7.4% 87,615 $160K
Kennedy Capital Management LLC 0.00% New 76,513 $139K
Penbrook Management LLC 0.08% Reduce -9.5% 69,455 $126K
Palumbo Wealth Management LLC 0.05% Add +265.5% 66,669 $121K
UBS Group AG 0.00% No change 62,516 $114K
Nantahala Capital Management, LLC 0.01% Reduce -20.2% 59,316 $108K
BlackRock Inc. 0.00% Reduce -21.5% 43,566 $79K
State Street Corp. 0.00% No change 27,691 $50K
Citadel Advisors 0.00% Add +250.5% 25,379 $46K
Bridgeway Capital Management, LLC 0.00% Reduce -46.6% 21,800 $40K
Prudential Financial Inc. 0.00% Add +10.1% 21,800 $40K
Dimensional Fund Advisors LP 0.00% Reduce -20.4% 21,039 $38K
Northern Trust Corp. 0.00% Reduce -0.4% 16,307 $30K
Millennium Management 0.00% Reduce -39.6% 14,403 $26K
First Bank & Trust 0.01% No change 13,518 $25K
Allworth Financial LP 0.00% No change 7,015 $14K
Tower Research Capital LLC (TRC) 0.00% Add +57.3% 6,303 $11K
Bank of America Corp. 0.00% Add +1.2% 6,092 $11K
Barclays PLC 0.00% No change 5,145 $9K
Wells Fargo & Company 0.00% Reduce -2.9% 2,387 $4K
Simplex Trading, LLC 0.00% New 634 $1K
Qube Research & Technologies Ltd 0.00% No change 204 $372
JPMorgan Chase & Co. 0.00% Add +2.9% 35 $64
Royal Bank of Canada 0.00% Add +169.3% 237 $0

"% of holder's portfolio" is XGN's weight in each manager's 13F, not the share of Exagen Inc. the manager owns.